371 related articles for article (PubMed ID: 34663907)
1. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.
Matsuyama T; Yoshinaga SK; Shibue K; Mak TW
Cell Death Differ; 2021 Dec; 28(12):3199-3213. PubMed ID: 34663907
[TBL] [Abstract][Full Text] [Related]
2. An aberrant STAT pathway is central to COVID-19.
Matsuyama T; Kubli SP; Yoshinaga SK; Pfeffer K; Mak TW
Cell Death Differ; 2020 Dec; 27(12):3209-3225. PubMed ID: 33037393
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19.
Al-Tamimi AO; Yusuf AM; Jayakumar MN; Ansari AW; Elhassan M; AbdulKarim F; Kannan M; Halwani R; Ahmad F
Int J Lab Hematol; 2022 Aug; 44(4):712-721. PubMed ID: 35266284
[TBL] [Abstract][Full Text] [Related]
5. Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era.
Li Y; Cui X; Zhu N; Lin Y; Li X
Front Cell Infect Microbiol; 2024; 14():1338508. PubMed ID: 38390620
[TBL] [Abstract][Full Text] [Related]
6. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
Suárez-Reyes A; Villegas-Valverde CA
MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
[TBL] [Abstract][Full Text] [Related]
7. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider.
Najm A; Alunno A; Mariette X; Terrier B; De Marco G; Emmel J; Mason L; McGonagle DG; Machado PM
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33574116
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.
Lopez-Castaneda S; García-Larragoiti N; Cano-Mendez A; Blancas-Ayala K; Damian-Vázquez G; Perez-Medina AI; Chora-Hernández LD; Arean-Martínez C; Viveros-Sandoval ME
Clin Appl Thromb Hemost; 2021; 27():1076029621999099. PubMed ID: 33835872
[TBL] [Abstract][Full Text] [Related]
10. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
Jiménez-Cortegana C; Sánchez-Jiménez F; Pérez-Pérez A; Álvarez N; Sousa A; Cantón-Bulnes L; Vilariño-García T; Fuentes S; Martín S; Jiménez M; León-Justel A; de la Cruz-Merino L; Garnacho-Montero J; Sánchez-Margalet V
Front Immunol; 2021; 12():801410. PubMed ID: 35154077
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale.
Ferrarotti I; Ottaviani S; Balderacchi AM; Barzon V; De Silvestri A; Piloni D; Mariani F; Corsico AG
Respir Med; 2021 Jul; 183():106440. PubMed ID: 33964815
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
13. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations.
Cava E; Neri B; Carbonelli MG; Riso S; Carbone S
Clin Nutr; 2021 Apr; 40(4):1637-1643. PubMed ID: 33765600
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
Sci Rep; 2021 Jan; 11(1):1580. PubMed ID: 33452298
[TBL] [Abstract][Full Text] [Related]
15. The Weight of Obesity in Immunity from Influenza to COVID-19.
Andrade FB; Gualberto A; Rezende C; Percegoni N; Gameiro J; Hottz ED
Front Cell Infect Microbiol; 2021; 11():638852. PubMed ID: 33816341
[TBL] [Abstract][Full Text] [Related]
16. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Periodontitis-Derived Dark-NETs in Severe Covid-19.
Vitkov L; Knopf J; Krunić J; Schauer C; Schoen J; Minnich B; Hannig M; Herrmann M
Front Immunol; 2022; 13():872695. PubMed ID: 35493525
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection.
Barnes HW; Demirdjian S; Haddock NL; Kaber G; Martinez HA; Nagy N; Karmouty-Quintana H; Bollyky PL
Matrix Biol; 2023 Feb; 116():49-66. PubMed ID: 36750167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
